Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pfizer Inc (PFE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Healthcare ETFs to Watch As Q4 Earnings Unfold

With earnings surprises well in the cards, the healthcare sector is expected to witness earnings growth of 3% in the fourth quarter, suggesting some upside for healthcare ETFs.

XLV : 89.02 (+0.66%)
VHT : 166.18 (+1.01%)
JNJ : 148.14 (+0.53%)
MRK : 61.25 (-0.05%)
IYH : 187.51 (+0.96%)
FHLC : 43.11 (+1.01%)
ABBV : 106.49 (+1.77%)
GILD : 81.41 (+0.53%)
AMGN : 192.33 (+1.61%)
PFE : 36.93 (-0.03%)
BMY : 63.28 (+1.61%)
Merck Reports Positive Phase III Liver Cancer Data on Keytruda

Merck (MRK), announces first time results from the phase II study evaluating the use Keytruda in patients with advanced hepatocellular carcinoma (HCC), previously treated with sorafenib.

MRK : 61.25 (-0.05%)
LLY : 85.44 (-0.06%)
AMGN : 192.33 (+1.61%)
PFE : 36.93 (-0.03%)
Healthcare ETFs to Watch As Q4 Earnings Unfold

With earnings surprises well in the cards, the healthcare sector is expected to witness earnings growth of 3% in the fourth quarter, suggesting some upside for healthcare ETFs.

XLV : 89.02 (+0.66%)
VHT : 166.18 (+1.01%)
JNJ : 148.14 (+0.53%)
MRK : 61.25 (-0.05%)
IYH : 187.51 (+0.96%)
FHLC : 43.11 (+1.01%)
ABBV : 106.49 (+1.77%)
GILD : 81.41 (+0.53%)
AMGN : 192.33 (+1.61%)
PFE : 36.93 (-0.03%)
BMY : 63.28 (+1.61%)
Gilead Collaborates with Pfizer for Yescarta Combo Study

Kite, a Gilead Company (GILD), announced that it inked a clinical trial collaboration with Pfizer, for combination study.

NVS : 87.00 (+0.07%)
GILD : 81.41 (+0.53%)
PFE : 36.93 (-0.03%)
JUNO : 86.00 (+26.82%)
Pharma Stock Roundup: Merck's Keytruda Shines in Study, Priority Review for Kymriah Label Expansion

Focus this week was on Merck's (MRK) data on Keytruda as well as Novartis's updates on Kymriah and its biosimilar efforts.

JNJ : 148.14 (+0.53%)
MRK : 61.25 (-0.05%)
NVS : 87.00 (+0.07%)
GILD : 81.41 (+0.53%)
PFE : 36.93 (-0.03%)
GSK : 38.56 (+0.94%)
BMY : 63.28 (+1.61%)
The Zacks Analyst Blog Highlights: Pfizer, Chevron, Cisco, Las Vegas Sands and Dominion Resources

The Zacks Analyst Blog Highlights: Pfizer, Chevron, Cisco, Las Vegas Sands and Dominion Resources

CSCO : 41.66 (+0.90%)
D : 74.89 (-0.13%)
CVX : 132.56 (+0.96%)
LVS : 77.10 (+3.48%)
PFE : 36.93 (-0.03%)
J&J (JNJ) to Set Pharma Q4 Earnings in Motion: What's Up?

The positive trend seen in J&J's (JNJ) pharma segment sales in Q3 is likely to continue in Q4. Strong pharma performance and contribution from acquisitions should support the top line.

JNJ : 148.14 (+0.53%)
MRK : 61.25 (-0.05%)
PFE : 36.93 (-0.03%)
GSK : 38.56 (+0.94%)
Top Stock Reports for Pfizer, Chevron & Cisco

Top Stock Reports for Pfizer, Chevron & Cisco

TGT : 78.58 (+0.61%)
CSCO : 41.66 (+0.90%)
D : 74.89 (-0.13%)
CVX : 132.56 (+0.96%)
LVS : 77.10 (+3.48%)
PFE : 36.93 (-0.03%)
Buy These 3 Stocks to Trade Like An Institutional Investor

Wall Street is already off to a hot start in the New Year, with the Dow surging to new heights and tech giants like Amazon (AMZN) and Nvidia (NVDA) picking up right where they left off. But as tempting...

MSFT : 91.61 (+1.79%)
NVDA : 233.69 (+1.56%)
BAC : 31.94 (+0.69%)
PFE : 36.93 (-0.03%)
AMZN : 1,327.31 (+2.53%)
SmarTrend Watching for Potential Pullback in Shares of Pfizer Inc After 1.41% Gain

Pfizer Inc (NYSE:PFE) traded in a range yesterday that spanned from a low of $36.76 to a high of $37.16. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $36.98...

PFE : 36.93 (-0.03%)
Exelixis, Ipsen Report Positive Results on Lead Cancer Drug

Exelixis (EXEL) and Ipsen announce detailed results from the late stage study of lead drug Cabometyx in patients with previously treated advanced HCC.

EXEL : 29.44 (+5.14%)
RHHBY : 30.7900 (+0.33%)
PFE : 36.93 (-0.03%)
BMY : 63.28 (+1.61%)
Will Amgen (AMGN) Continue to Tread Growth Path This Year?

Amgen (AMGN) stock outperformed the industry in 2017. We will have to wait and see if it can keep the momentum alive in 2018.

AGN : 188.15 (+3.76%)
RHHBY : 30.7900 (+0.33%)
AMGN : 192.33 (+1.61%)
PFE : 36.93 (-0.03%)
Foundation Medicine and Pfizer Announce Broad Partnership to Develop Companion Diagnostics for Pfizer's Oncology Portfolio

Foundation Medicine, Inc. (NASDAQ:FMI) today announced that the company has entered into a broad partnership with Pfizer Inc. (NYSE: PFE). The partnership focuses on development, regulatory...

FMI : 70.15 (+4.31%)
PFE : 36.93 (-0.03%)
Glaxo's Influenza Vaccine Gets FDA Nod for Label Expansion

Glaxo's (GSK) influenza vaccine ??? Fluarix Quadrivalent receives FDA approval for label expansion.

NVS : 87.00 (+0.07%)
EXEL : 29.44 (+5.14%)
PFE : 36.93 (-0.03%)
GSK : 38.56 (+0.94%)
Ligand (LGND) Inks Deal With Glenmark for OmniAb Platform

Ligand (LGND) enters into a worldwide license agreement with Glenmark for OmniAb platform.

LGND : 159.60 (+2.43%)
MRK : 61.25 (-0.05%)
NVS : 87.00 (+0.07%)
PFE : 36.93 (-0.03%)
Dow 30 Stock Roundup: Boeing Q4 Deliveries Up Y/Y, Success for Merck's Keytruda Combo

The Dow endured a volatile week during which the index hit a fresh record high.

AAPL : 177.00 (-0.82%)
SNP : 84.09 (+0.14%)
KO : 47.38 (+0.47%)
CVX : 132.56 (+0.96%)
JPM : 114.33 (+1.17%)
JNJ : 148.14 (+0.53%)
MRK : 61.25 (-0.05%)
LLY : 85.44 (-0.06%)
GS : 261.52 (+2.11%)
PFE : 36.93 (-0.03%)
BA : 338.00 (+0.08%)
Merck's Keytruda on a Roll: Can it Retain the Spark in 2018?

Merck's (MRK) Keytruda rapidly grows as its key top-line driver. The Keytruda development program shows significant advancement in 2017.

MRK : 61.25 (-0.05%)
LLY : 85.44 (-0.06%)
AMGN : 192.33 (+1.61%)
PFE : 36.93 (-0.03%)
Pharma Stock Roundup: Novo Nordisk Reveals Bid to Acquire Ablynx, Pfizer & Others at Healthcare Conference

Focus this week was on pipeline updates provided by several companies including Pfizer (PFE) at a healthcare conference while Novo Nordisk's bid to acquire Ablynx also made news.

NVO : 57.95 (+0.28%)
JNJ : 148.14 (+0.53%)
MRK : 61.25 (-0.05%)
PFE : 36.93 (-0.03%)
GSK : 38.56 (+0.94%)
SNY : 43.20 (-3.14%)
BMY : 63.28 (+1.61%)
Parkinson's Disease Space Again Under Spotlight This Week

Parkinson's Disease emerges a lucrative area in want of curative therapies in the space. To this end, many players work toward launching new treatments in the market.

ADMS : 40.79 (+6.81%)
NVS : 87.00 (+0.07%)
TEVA : 21.02 (+1.55%)
PFE : 36.93 (-0.03%)
Key Takeaways from Pfizer & 3 Other Drug Stocks at Healthcare Conference

Here is a look at key takeaways from presentations made by four major pharma and biotech stocks including Pfizer (PFE) at the annual J.P. Morgan healthcare conference.

CELG : 102.91 (+0.25%)
MRK : 61.25 (-0.05%)
PFE : 36.93 (-0.03%)
BMY : 63.28 (+1.61%)

Van Meerten Stock Picks

My 5 Favorite Mid Cap Stocks
This morning I wanted to find 5 Mid Cap stocks that had great returns over the past year and still seem to have some juice left.
KBH +0.03 , IPGP -2.30 , FSLR -1.07 , NVR -45.00 , SGMS -0.03
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Mar E-mini S&Ps ( ESH18 -0.06% ) this morning are down -0.07% as the partial shutdown of the U.S. government begins for a third day. The Senate has a vote scheduled for 12pm Eastern time to sees if the impasse... Read More

Chart of the Day

Chart of the Day

Catalyst Biosciences (CBIO) is the Barchart Chart of the Day.  The biomedical company has a Trend Spotter buy signal, a Weighted Alpha of 150.22+ and gined 111.86% in the last year.
Read More

Brugler Ag Report

Today's Commentary

Corn futures closed the day fractionally on either side of UNCH. The Senate Monday afternoon passed a short terms spending bill, ending the three day government shutdown. This morning's USDA Export Inspections report, not affected by the government s...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.